Jerome T. Higgs, Ph.D.
Affiliations: | 2013 | Pathology | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Pathology, OncologyGoogle:
"Jerome Higgs"Parents
Sign in to add mentor| Selvarangan Ponnazhagan | grad student | 2013 | UAB | |
| (Therapeutic potential of genetically engineered mesenchymal stem cells in multiple myeloma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Higgs JT, Lee JH, Wang H, et al. (2017) Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma. Blood Advances. 1: 2375-2385 |
| Chanda D, Hensel JA, Higgs JT, et al. (2017) Effects of Cellular Methylation on Transgene Expression and Site-Specific Integration of Adeno-Associated Virus. Genes. 8 |
| Higgs JT, Jarboe JS, Lee JH, et al. (2015) Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. Molecular Cancer Research : McR. 13: 819-27 |
| Higgs JT. (2013) Abstract 2240: Structural variant of osteoprotegerin lacking TRAIL binding for therapeutic bone remodeling in osteolytic malignancies. Cancer Research. 73: 2240-2240 |
| Higgs JT, Jarboe J, Ponnazhagan S. (2012) Abstract 4943: Genetically engineered osteoprotegerin for multiple myeloma osteolytic bone damage Cancer Research. 72: 4943-4943 |
| Higgs JT, Jarboe J, Ponnazhagan S. (2011) Abstract 3391: Regenerative stem cell therapy for multiple myeloma osteolytic bone damage Cancer Research. 71: 3391-3391 |